Search Results - "MERCIER, Marjorie"
-
1
Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases
Published in Cancer research (Chicago, Ill.) (15-08-2012)“…Lymphoid neogenesis, or the development of lymphoid structures in nonlymphoid organs, is frequently observed in chronically inflamed tissues, during the course…”
Get full text
Journal Article -
2
The development of cortical connections
Published in The European journal of neuroscience (01-02-2006)“…The cortex receives its major sensory input from the thalamus via thalamocortical axons, and cortical neurons are interconnected in complex networks by…”
Get full text
Journal Article -
3
74 a-TIGIT mAb belrestotug in combination with anti-PD1 induces an immunocompetent tumor microenvironment (TME)
Published in Journal for immunotherapy of cancer (01-11-2023)“…BackgroundT cell immunoglobulin and ITIM domain (TIGIT) is an immune checkpoint inhibitor expressed mainly on NK and T cell populations. Antagonist a-TIGIT…”
Get full text
Journal Article -
4
Abstract 4154: EOS100850 inhibits A2A receptor signaling in human whole blood: Two pharmacodynamic assays to monitor EOS100850 activity in clinical studies
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract High levels of extracellular adenosine in the tumor microenvironment promote tumor immune evasion. We and others have shown that adenosine,…”
Get full text
Journal Article -
5
Restoration of T-cell Effector Function, Depletion of Tregs, and Direct Killing of Tumor Cells: The Multiple Mechanisms of Action of a-TIGIT Antagonist Antibodies
Published in Molecular cancer therapeutics (01-01-2021)“…TIGIT is an immune checkpoint inhibitor expressed by effector CD4 and CD8 T cells, NK cells, and regulatory T cells (Tregs). Inhibition of TIGIT-ligand binding…”
Get full text
Journal Article -
6
Abstract 3240: EOS884448, a high affinity fully human antibody directed against TIGIT, mediates in vitro anti-tumor activity through multiples mechanisms of action involving activation of intratumor effector cells and depletion of regulatory T cells
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract T cell Immunoreceptor with Ig and ITIM domains (TIGIT) is a T cell co-inhibitory receptor recently described as a key checkpoint driving tumor cell…”
Get full text
Journal Article -
7
Abstract 4149: Extensive characterization of the adenosine pathway in human solid tumors gives a hint on cancer indication selection for the A2A receptor antagonist EOS100850
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Extracellular adenosine is an immunosuppressive metabolite generated by sequential action of the two ectonucleotidases CD39 and CD73. Tissue hypoxia,…”
Get full text
Journal Article -
8
Abstract 3161: Preparation of aclinical trial with a-TIGIT antagonist antibody EOS884448, which demonstrates potent preclinical activity and safe toxicology profile
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract T cell Immunoreceptor with Ig and ITIM domains (TIGIT) is a co-inhibitory receptor expressed by lymphocytes, preferentially CD8+, NK, as well as by…”
Get full text
Journal Article -
9
Abstract 4969: TIGIT pathway phenotyping sheds light on promising strategies to restore anti-tumor immunity
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract TIGIT is a T cell co-inhibitory receptor recently described as a key checkpoint driving tumor cell immunosuppression. It is predominantly expressed on…”
Get full text
Journal Article -
10
Plasma cells in primary melanoma. Prognostic significance and possible role of IgA
Published in Modern pathology (01-04-2016)“…Melanoma is not only one of the most immunogenic cancers but also one of the most effective cancers at subverting host immunity. The role of T lymphocytes in…”
Get full text
Journal Article -
11
Abstract LB-114: a-TIGIT antagonist antibody EOS884448 shows dual mechanism of action by restoration of T cell effector functions and preferential depletion of Treg
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract T cell Immunoreceptor with Ig and ITIM domains (TIGIT) is a co-inhibitory receptor expressed by lymphocytes, preferentially CD8+ T cells, NK, as well…”
Get full text
Journal Article -
12
Abstract 3278: EOS100850 potently restores adenosine A2Areceptor-dependent suppression of T cell function in the adenosine rich tumor microenvironment
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Adenosine is a potent immunosuppressive metabolite that is often found elevated in the extracellular tumor microenvironment (TME). We determined…”
Get full text
Journal Article -
13
Abstract 4135: A novel plasma cell-based mechanism of action of adenosine immunomodulation and A2AR antagonism
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract High levels of extracellular adenosine, often found in the tumor microenvironment (TME), promote immune suppression mainly through the A2A receptor…”
Get full text
Journal Article -
14
Abstract LB189: Pharmacodynamic assessment of a-TIGIT mAb EOS-448 highlights multiple FcγR-mediated mode-of-actions in blood and tumor of patients with advanced solid tumors
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract T cell immunoglobulin and ITIM domain (TIGIT) is an immune checkpoint inhibitor expressed mainly on NK and T cell populations which has demonstrated…”
Get full text
Journal Article -
15
REVIEW ARTICLE: The development of cortical connections
Published in The European journal of neuroscience (01-02-2006)“…The cortex receives its major sensory input from the thalamus via thalamocortical axons, and cortical neurons are interconnected in complex networks by…”
Get full text
Journal Article